James George Chopas - 15 Sep 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Issuer symbol
APLS
Transactions as of
15 Sep 2025
Net transactions value
-$4,572
Form type
4
Filing time
17 Sep 2025, 20:08:01 UTC
Previous filing
03 Sep 2025
Next filing
15 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chopas James George VP/Chief Accounting Officer C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM /s/ David Watson, attorney-in-fact for James Chopas 16 Sep 2025 0001836430

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $4,572 -189 -0.35% $24.19 53,468 15 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on September 12, 2025.